SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VERISANTE TECHNOLOGY
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: andre dallaire who wrote (101)5/7/2012 5:12:32 PM
From: Terry Maloney   of 254
 
Very good report, though I found their sales projections quite low ... perhaps Aura's going to be a somewhat tough sell in countries with socialized medicine, since scans aren't covered, apparently.

Whereas biopsies are, I imagine (certainly here in Quebec, at least) ... I wonder how much biopsies cost the health systems, and whether that's not the price VRS should be looking at.

Otherwise they might just be looking at a niche market of people who are willing to pay $200 to jump the queue ... which might well be worth it for melanoma, but probably not so much for the others.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News